IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i20p10644-d653607.html
   My bibliography  Save this article

A Comprehensive Descriptive Epidemiological and Clinical Analysis of SARS-CoV-2 in West-Mexico during COVID-19 Pandemic 2020

Author

Listed:
  • Oliver Viera-Segura

    (Laboratorio de Diagnóstico de Enfermedades Emergentes y Reemergentes, Departamento de Microbiología y Patología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico)

  • Natali Vega-Magaña

    (Laboratorio de Diagnóstico de Enfermedades Emergentes y Reemergentes, Departamento de Microbiología y Patología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico
    Instituto de Investigación de Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico)

  • Mariel García-Chagollán

    (Instituto de Investigación de Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico)

  • Marcela Peña-Rodríguez

    (Laboratorio de Diagnóstico de Enfermedades Emergentes y Reemergentes, Departamento de Microbiología y Patología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico
    Centro de Investigación y Diagnóstico de Patologia, Departamento de Microbiología y Patología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico)

  • Germán Muñoz-Sánchez

    (Doctorado en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico)

  • Ahtziri Socorro Carranza-Aranda

    (Doctorado en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico)

  • Iris Monserrat Llamas-Covarrubias

    (Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, CP, Mexico)

  • Moisés Ramos-Solano

    (INICIA, CUCS Universidad de Guadalajara, Guadalajara 44340, Mexico)

  • Jesús Mora-Mora

    (Laboratorio de Diagnóstico de Enfermedades Emergentes y Reemergentes, Departamento de Microbiología y Patología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico
    Maestría en Ciencias Médicas, Universidad de Colima, Colima 28040, Mexico)

  • Carlos Daniel Díaz-Palomera

    (Laboratorio de Diagnóstico de Enfermedades Emergentes y Reemergentes, Departamento de Microbiología y Patología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico
    Doctorado en Ciencias en Biología Molecular en Medicina, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico)

  • Gabriela Espinoza-De León

    (Laboratorio de Diagnóstico de Enfermedades Emergentes y Reemergentes, Departamento de Microbiología y Patología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico)

  • José Sergio Zepeda-Nuño

    (Centro de Investigación y Diagnóstico de Patologia, Departamento de Microbiología y Patología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico)

  • Enrique Santillán-López

    (Doctorado en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico)

  • Samuel García-Arellano

    (Instituto de Investigación de Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico)

  • Christian David Hernández-Silva

    (Doctorado en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico)

  • Darbi Alfredo Zerpa-Hernandez

    (Instituto de Investigación de Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico
    Doctorado en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico)

  • Guillermina Muñoz-Rios

    (Laboratorio de Diagnóstico de Enfermedades Emergentes y Reemergentes, Departamento de Microbiología y Patología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico
    Doctorado en Ciencias Médicas, Universidad de Colima, Colima 280440, Mexico)

  • J. Samael Rodríguez-Sanabria

    (Doctorado en Ciencias en Biología Molecular en Medicina, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico)

  • José Francisco Muñoz-Valle

    (Instituto de Investigación de Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico)

Abstract

This study aimed to summarize the epidemiological and clinical characteristics of COVID-19 from Western Mexico people during 2020. A retrospective analysis from an electronic database of people visiting a sentinel center for molecular SARS-CoV-2 confirmatory diagnosis by RT-PCR from April to December 2020 was carried out for epidemiological and clinical description of COVID-19. Out of 23,211 patients evaluated, 6918 (29.8%) were confirmed for SARS-CoV-2 infection (mean age 38.5 ± 13.99), mostly females (53.8%). Comorbidities, such as diabetes (34.7%), obesity (31.15%), and hypertension (31.8%), presented an increased odds OR = 1.27, CI = 1.14–1.41; OR = 1.08, CI = 1.01–1.16; and OR = 1.09, CI = 0.99–1.19, respectively, for viral-infection. Moreover, fever, headache, and dry cough were the most frequent symptoms. No infection difference among sex was found. Those patients >60 years old were prone to COVID-19 severity (OR = 3.59, CI = 2.10–6.14), evaluated by the number of manifested symptoms, increasing with age. In conclusion, a high SARS-CoV-2 prevalence was found in Western Mexico. Comorbidities were frequent in infected people; nevertheless, no association with disease outcomes was observed, in contrast with the highest disease severity risk found in older patients; however, continuous monitoring should be carried since comorbidities have been reported as aggravating factors. This study can help the health officials for the elaboration of planning efforts of the disease management and others in the future.

Suggested Citation

  • Oliver Viera-Segura & Natali Vega-Magaña & Mariel García-Chagollán & Marcela Peña-Rodríguez & Germán Muñoz-Sánchez & Ahtziri Socorro Carranza-Aranda & Iris Monserrat Llamas-Covarrubias & Moisés Ramos-, 2021. "A Comprehensive Descriptive Epidemiological and Clinical Analysis of SARS-CoV-2 in West-Mexico during COVID-19 Pandemic 2020," IJERPH, MDPI, vol. 18(20), pages 1-13, October.
    • Handle: RePEc:gam:jijerp:v:18:y:2021:i:20:p:10644-:d:653607
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/20/10644/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/18/20/10644/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Michael C Grant & Luke Geoghegan & Marc Arbyn & Zakaria Mohammed & Luke McGuinness & Emily L Clarke & Ryckie G Wade, 2020. "The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries," PLOS ONE, Public Library of Science, vol. 15(6), pages 1-19, June.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Najeeb Ullah & Khurshid Ahmad Khan & Javeid Iqbal & Asim Rana & Bilal Bin Younis & Mohsin Asif & Aijaz Zeeshan Khan Chachar & Falak shan, 2020. "Efficacy of Remdesivir in Covid-19 Patients; Multicenter Study in Lahore," International Journal of Sciences, Office ijSciences, vol. 9(11), pages 31-34, November.
    2. Nikola Anđelić & Sandi Baressi Šegota & Ivan Lorencin & Zdravko Jurilj & Tijana Šušteršič & Anđela Blagojević & Alen Protić & Tomislav Ćabov & Nenad Filipović & Zlatan Car, 2021. "Estimation of COVID-19 Epidemiology Curve of the United States Using Genetic Programming Algorithm," IJERPH, MDPI, vol. 18(3), pages 1-26, January.
    3. Caterina Alacevich & Inna Thalmann & Catia Nicodemo & Simon Lusignan & Stavros Petrou, 2023. "Symptomatic SARS-CoV-2 Episodes and Health-Related Quality of Life," Applied Health Economics and Health Policy, Springer, vol. 21(5), pages 761-771, September.
    4. Carol Nash, 2020. "Report on Digital Literacy in Academic Meetings during the 2020 COVID-19 Lockdown," Challenges, MDPI, vol. 11(2), pages 1-24, September.
    5. Matthew Whitaker & Joshua Elliott & Barbara Bodinier & Wendy Barclay & Helen Ward & Graham Cooke & Christl A. Donnelly & Marc Chadeau-Hyam & Paul Elliott, 2022. "Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England," Nature Communications, Nature, vol. 13(1), pages 1-10, December.
    6. Abbasi-Kangevari, Mohsen & Ghanbari, Ali & Malekpour, Mohammad-Reza & Ghamari, Seyyed-Hadi & Azadnajafabad, Sina & Saeedi Moghaddam, Sahar & Keykhaei, Mohammad & Haghshenas, Rosa & Golestani, Ali & Ra, 2023. "Exploring the clinical benefit of ventilation therapy across various patient groups with COVID-19 using real-world data," Open Access Publications from Kiel Institute for the World Economy 273506, Kiel Institute for the World Economy (IfW Kiel).
    7. Nguyen, My, 2020. "Mask Mandates and COVID-19 Related Symptoms in the US," MPRA Paper 109992, University Library of Munich, Germany.
    8. Bo Zhao & Fanlei Kong & Myo Nyein Aung & Motoyuki Yuasa & Eun Woo Nam, 2020. "Novel Coronavirus (COVID-19) Knowledge, Precaution Practice, and Associated Depression Symptoms among University Students in Korea, China, and Japan," IJERPH, MDPI, vol. 17(18), pages 1-17, September.
    9. Laurent Gerbaud & Candy Guiguet-Auclair & Franck Breysse & Joséphine Odoul & Lemlih Ouchchane & Jonathan Peterschmitt & Camille Dezfouli-Desfer & Vincent Breton, 2020. "Hospital and Population-Based Evidence for COVID-19 Early Circulation in the East of France," IJERPH, MDPI, vol. 17(19), pages 1-17, September.
    10. Yuen, Kum Fai & Cai, Lanhui & Wee, Shaun Chuin Kit & Wang, Xueqin, 2024. "Pandemic-driven acceptance of urban drone deliveries," Transport Policy, Elsevier, vol. 146(C), pages 356-370.
    11. Erika Christina Gouveia e Silva & Ana Carolina Basso Schmitt & Caroline Gil de Godoy & Danielle Brancolini de Oliveira & Clarice Tanaka & Carlos Toufen & Carlos Roberto Ribeiro de Carvalho & Celso R. , 2023. "Risk Factors for the Impairment of Ambulation in Older People Hospitalized with COVID-19: A Retrospective Cohort Study," IJERPH, MDPI, vol. 20(22), pages 1-10, November.
    12. Arthur Eumann Mesas & Iván Cavero-Redondo & Celia Álvarez-Bueno & Marcos Aparecido Sarriá Cabrera & Selma Maffei de Andrade & Irene Sequí-Dominguez & Vicente Martínez-Vizcaíno, 2020. "Predictors of in-hospital COVID-19 mortality: A comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions," PLOS ONE, Public Library of Science, vol. 15(11), pages 1-23, November.
    13. Marcin Januszewski & Laura Ziuzia-Januszewska & Alicja A. Jakimiuk & Waldemar Wierzba & Anna Gluszko & Joanna Zytynska-Daniluk & Artur J. Jakimiuk, 2021. "Is the Course of COVID-19 Different during Pregnancy? A Retrospective Comparative Study," IJERPH, MDPI, vol. 18(22), pages 1-15, November.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:20:p:10644-:d:653607. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.